XML 90 R79.htm IDEA: XBRL DOCUMENT v3.25.3
POLICY LIABILITIES - Summary of Net Earned Premiums Recognized (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Liability for Future Policy Benefit, Activity [Line Items]        
Reinsurance ceded $ (92) $ (71) $ (271) $ (206)
Net earned premiums [1] 3,372 3,328 10,223 10,109
Aflac Japan | Cancer        
Liability for Future Policy Benefit, Activity [Line Items]        
Gross premiums 850 885 2,574 2,595
Aflac Japan | Medical and other health        
Liability for Future Policy Benefit, Activity [Line Items]        
Gross premiums 535 577 1,621 1,752
Aflac Japan | Life insurance        
Liability for Future Policy Benefit, Activity [Line Items]        
Gross premiums 281 251 925 906
Aflac Japan | Other        
Liability for Future Policy Benefit, Activity [Line Items]        
Gross premiums 34 35 99 104
Aflac U.S. | Life insurance        
Liability for Future Policy Benefit, Activity [Line Items]        
Gross premiums 171 141 510 420
Aflac U.S. | Accident        
Liability for Future Policy Benefit, Activity [Line Items]        
Gross premiums 305 314 925 955
Aflac U.S. | Disability        
Liability for Future Policy Benefit, Activity [Line Items]        
Gross premiums 349 333 1,055 998
Aflac U.S. | Critical Care        
Liability for Future Policy Benefit, Activity [Line Items]        
Gross premiums 439 439 1,323 1,324
Aflac U.S. | Hospital Indemnity        
Liability for Future Policy Benefit, Activity [Line Items]        
Gross premiums 181 181 548 548
Aflac U.S. | Dental/Vision        
Liability for Future Policy Benefit, Activity [Line Items]        
Gross premiums 52 54 153 159
Aflac U.S. | Other        
Liability for Future Policy Benefit, Activity [Line Items]        
Gross premiums 53 29 143 75
Corporate and other        
Liability for Future Policy Benefit, Activity [Line Items]        
Gross premiums $ 214 $ 160 $ 618 $ 479
[1] Includes a gain (loss) of $(55) and $(75) for the three-month periods and $(55) and $(80) for the nine-month periods ended September 30, 2025 and 2024, respectively, related to remeasurement of the deferred profit liability for limited-payment contracts.